scispace - formally typeset
L

Lori Hassard

Researcher at Western University College of Veterinary Medicine

Publications -  14
Citations -  1871

Lori Hassard is an academic researcher from Western University College of Veterinary Medicine. The author has contributed to research in topics: Porcine circovirus & Circovirus. The author has an hindex of 12, co-authored 14 publications receiving 1800 citations. Previous affiliations of Lori Hassard include Merial.

Papers
More filters
Journal Article

Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome.

TL;DR: Results demonstrate a high degree of association between the presence of the circovirus-like virus and postweaning multisystemic wasting syndrome in affected swine.
Journal ArticleDOI

Characterization of novel circovirus DNAs associated with wasting syndromes in pigs.

TL;DR: Cl cloning and characterization of novel circovirus DNAs purified from virus isolates made from tissues of North American and European pigs with wasting syndromes are reported, providing evidence for a new type of possibly pathogenic PCV.
Journal ArticleDOI

Reproduction of Lesions of Postweaning Multisystemic Wasting Syndrome in Gnotobiotic Piglets

TL;DR: It is demonstrated that the lesions of PMWS can be experimentally reproduced in gnotobiotic piglets using filterable viral agents derived from pigs with PMWS and provide an experimental basis for further investigation into the pathogenesis and control of this emerging infectious disease in swine.
Journal ArticleDOI

Coinfection by porcine circoviruses and porcine parvovirus in pigs with naturally acquired postweaning multisystemic wasting syndrome.

TL;DR: Findings confirm and extend previous findings documenting a consistent association of PCV 2 with PMWS and suggest infection by PPV or PCV 1 or both may be an important cofactor in the pathogenesis of some, but apparently not all, cases of PMWS.
Journal Article

Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus.

TL;DR: A single dose of a modified-live type-I isolate of BVDV vaccine protects young calves from clinical signs of disease associated with type-II isolates and determines which type of immune response correlates with protection.